Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation. [electronic resource]
Producer: 20160315Description: 1492-6 p. digitalISSN:- 1474-4457
- Adult
- Africa South of the Sahara
- Anti-HIV Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- Antitubercular Agents -- therapeutic use
- Coinfection
- Drug Combinations
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Isoniazid -- therapeutic use
- Male
- Mycobacterium tuberculosis -- drug effects
- Tablets
- Time Factors
- Trimethoprim, Sulfamethoxazole Drug Combination -- therapeutic use
- Tuberculosis, Pulmonary -- microbiology
- Vitamin B 6 -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.